To confirm the expression levels and mutation status of EGFR in the four NSCLC cell lines selected for this study (HCC827, H1975, H520 and H358), western blots and immunofluorescence experiments with specific antibodies were conducted (Fig. 5). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.